BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Nosology
,
Aspirin
,
rs2300478
,
EGFR
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
K-351
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells.
Protective action of nipradilol mediated through S-nitrosylation of Keap1 and HO-1 induction in reti…
Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subg…
Long-term study of nipradilol ophthalmic solution in patients with normal-tension glaucoma].
Route of penetration of topically instilled nipradilol into the ipsilateral posterior retina.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients Wi…
Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous…
A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ